Corprate Bias Ratings
AbbVie vets vendors according to LGBTQ policies and does not provide its employees with protections against viewpoint discrimination. However, it has not publicly terminated business relationships based on views or beliefs. The company covers the cost of "medically necessary transition-related care" for its employees and their children. AbbVie is a copper sponsor of Out & Equal and a corporate partner of the National LGBT Chamber of Commerce. The company funds the Human Rights Campaign (HRC) and advocates for the Equality Act. Allergan, a subsidiary of AbbVie, signed onto the Business Roundtable in 2019. For these reasons, AbbVie receives a Medium Risk rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
AbbVie does not appear to discriminate against religious organizations in its charitable giving. Its philanthropy focuses on strengthening healthcare systems, effective educational programs, and building strong communities. (1). AbbVie does partner with Habitat for Humanity, a faith-based charity (2).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
AbbVie has a perfect score on the HRC’s 2022 Corporate Equality Index. This score indicates the company covers the cost of “medically necessary transition-related care” for its employees and their children (1)(2). AbbVie is a sponsor of the HRC (3). AbbVie has pledged $62 million to Black Lives Matter and related causes (4)(5). AbbVie is a copper sponsor of Out & Equal and a corporate partner of the National LGBT Chamber of Commerce (6)(7). Allergan, a subsidiary of AbbVie, signed onto the Business Roundtable in 2019 (8).
All links were last accessed and all information was updated on:
November 27, 2023
Company reports are intended for educational use only. Full Disclaimer
|Date||ESG Category||Proponent||Summary of Resolution||Mgmt Rec||Total Vote % in Favor|
|5/5/23||Governance||John Chevedden||Simple Majority Voting||Against||53.90%|
|5/5/23||Governance||Dana Investment Advisers||Issue a Report on Lobbying||Against||35.70%|
|5/5/23||Governance||Friends Fiduciary Corporation||Issue a Report on Patent Process||Against||29.00%|
|5/5/23||Governance||As You Sow||Report on Political Spending||Against||14.90%|
|5/6/22||Governance||Kenneth Steiner||Shareholder Ratification of Termination Pay Exceeding 2.99x Total Pay||Against||50.10%|
|5/6/22||Social||As You Sow||Report on Political Spending||Against||39.32%|
|5/6/22||Governance||Friends Fiduciary Corp.||Board Oversight of Risks Related to Anticompetitive Practices||Against||32.82%|
|5/6/22||Governance||Rhode Island Employees Retirement System||Independent Board Chair||Against||30.18%|